Next-in-Class Once-Daily Pill Approved for Cystic Fibrosis

(MedPage Today) -- The FDA approved a once-daily oral combination of vanzacaftor/tezacaftor/deutivacaftor (Alyftrek) for cystic fibrosis (CF) in adults and children 6 years and up, drugmaker Vertex Pharmaceuticals announced on Friday.
Eligible...